Kevin Carson: The Predictable “Scandal” at the FDA

Protecting Big Business From Real Accountability


It’s gradually emerged in recent months that the Food and Drug Administration not only spied on its employees, but did so on a massive scale — collecting tens of thousands of employee emails to one another, as well as to journalists, members of Congress and congressional staff workers. The FDA also intercepted draft statements to the Office of Special Counsel, which investigates complaints of whistleblower harassment and reprisal. This monitoring, authorized by the agency’s chief counsel, was clearly a deliberate policy of the highest levels of FDA leadership.

Click here to continue reading ‘The Predictable “Scandal” at the FDA’ by Kevin Carson.

This site uses Akismet to reduce spam. Learn how your comment data is processed.